Literature DB >> 3594373

Mononuclear cell subsets in patients with oral cancer.

D P Eskinazi, J J Perna, R Mihail.   

Abstract

Peripheral mononuclear cells of ten patients with oral squamous cell carcinoma (SCC) and ten controls were evaluated for their cell subset composition. Flow cytometry experiments using commercially available subset-specific monoclonal antibodies (of the Leu series) were conducted to determine the percentage and fluorescent pattern of cell subsets. Leu-1+ (total T-cells), Leu-2a+ (T suppressor/cytotoxic cells), Leu-3a+ (T-helper/suppressor-inducer cells), Leu-7+ (natural killer cells), Leu-12+ (B-cells), and Leu-M3+ (monocytes) were analyzed. No significant difference was found between patients and controls in most instances; however, Leu-7+ cells were increased in patients (P less than 0.01). Preliminary experiments (and published evidence) suggest that this increase in Leu-7+ cells reflects an increase in natural killer cells, induced by a soluble factor released by squamous cell carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594373     DOI: 10.1002/1097-0142(19870801)60:3<376::aid-cncr2820600315>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  [Immunocytochemical venous blood studies in patients with manifest oral cavity carcinomas, oral precancerous conditions, benign tumors and in chronic alcoholic patients].

Authors:  R Dammer; E M Wurm; H Niederdellmann; H Fleischmann; R Knüchel
Journal:  Mund Kiefer Gesichtschir       Date:  1997-03

2.  Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic Correlations

Authors:  Thayalan Dineshkumar; Balakuntla Krishnamurthy Ashwini; Annasamy Rameshkumar; Padmanaban Rajashree; Ramadas Ramya; Krishnan Rajkumar
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

Review 3.  Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy.

Authors:  Roberto Rangel; Curtis R Pickering; Andrew G Sikora; Michael T Spiotto
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 8.786

4.  Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.

Authors:  Kazumasa Mori; Shigeki Haraguchi; Miki Hiori; Jun Shimada; Yoshihiro Ohmori
Journal:  BMC Cancer       Date:  2015-08-05       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.